Article
Mutation-Induced Resistance of SARS-CoV-2 Mpro to WU-04 Revealed by Multi-Scale Modeling.
International journal of molecular sciences - 19 Jan 2026
Liu Mengting, Zhao Derui, Duan Hui, Zhu Junyao, Zheng Liting, Yuan Nan, Xia Yuanling, Sang Peng, Yang Liquan
Abstract excerpt
The clinical durability of SARS-CoV-2 main protease (Mpro) inhibitors depends on their resilience to emerging resistance mutations. Recent genomic surveillance and functional reports have highlighted substitutions at positions 49, 165, and 301, raising questions about the robustness of the noncovalent inhibitor WU-04 in variant backgrounds. Here, we combined μs-scale, triplicate molecular dynamics simulations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
